Ensysce Biosciences (ENSC) Current Leases (2020 - 2023)
Ensysce Biosciences (ENSC) posted quarterly Current Leases of $2732.0 for Q3 2023, down 92.28% year-over-year from $35403.0 in Q3 2022, and down 75.0% quarter-over-quarter from $10926.0 in Q2 2023.
Ensysce Biosciences (ENSC) Current Leases (2020 - 2023) Analysis & Trends
Ensysce Biosciences (ENSC) has reported Current Leases for 4 consecutive years, with $2732.0 the latest figure, recorded in Q3 2023.
- In Q3 2023, Current Leases fell 92.28% year-over-year to $2732.0; the TTM figure through Sep 2023 stood at $2732.0 (down 92.28% YoY), while the FY2022 annual figure was $27315.0, up 9.81% from the prior year.
- Current Leases slipped to $2732.0 in Q3 2023 per ENSC's latest filing, from $10926.0 in the prior quarter.
- Across five years, Current Leases topped out at $35403.0 in Q3 2022 and bottomed at $2732.0 in Q3 2023.
- Historically, Current Leases has averaged $19615.1 across 4 years, with a median of $19120.0 in 2023.
- Annual changes were most pronounced in 2022 — Current Leases gained 11.8% — and 2023, when it plunged 92.28%.
- Ensysce Biosciences' Current Leases stood at $25500.0 in 2020, then fell by 2.45% to $24874.0 in 2021, then rose by 9.81% to $27315.0 in 2022, then slumped by 90.0% to $2732.0 in 2023.
- Business Quant data shows ENSC's Current Leases at $2732.0 in Q3 2023, $10926.0 in Q2 2023, and $19120.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 45.93 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 6.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Ensysce Biosciences | 960,039.34 | -3.35 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 2,732.00 |
| Jun 30, 2023 | 10,926.00 |
| Mar 31, 2023 | 19,120.00 |
| Dec 31, 2022 | 27,315.00 |
| Sep 30, 2022 | 35,403.00 |
| Jun 30, 2022 | 10,313.00 |
| Mar 31, 2022 | 17,716.00 |
| Dec 31, 2021 | 24,874.00 |
| Sep 30, 2021 | 31,667.00 |
| Jun 30, 2021 | 10,200.00 |
| Dec 31, 2020 | 25,500.00 |